Acadian Asset Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
2,074,604
+35,280
| +2% | +$21.5K | ﹤0.01% | 936 |
|
|
2025
Q1 | $1.54M | Buy |
2,039,324
+36,277
| +2% | +$27.4K | ﹤0.01% | 826 |
|
|
2024
Q4 | $1.93M | Buy |
2,003,047
+123,114
| +7% | +$118K | 0.01% | 774 |
|
|
2024
Q3 | $2.71M | Buy |
1,879,933
+794,840
| +73% | +$1.14M | 0.01% | 660 |
|
|
2024
Q2 | $1.31M | Buy |
1,085,093
+729,750
| +205% | +$882K | ﹤0.01% | 904 |
|
|
2024
Q1 | $834K | Sell |
355,343
-204,407
| -37% | -$480K | ﹤0.01% | 891 |
|
|
2023
Q4 | $1.06M | Buy |
559,750
+36,741
| +7% | +$69.3K | ﹤0.01% | 844 |
|
|
2023
Q3 | $715K | Buy |
523,009
+500,095
| +2,182% | +$684K | ﹤0.01% | 931 |
|
|
2023
Q2 | $54K | Buy |
+22,914
| New | +$54K | ﹤0.01% | 1514 |
|
|
2021
Q3 | – | Sell |
-4,843
| Closed | -$50K | – | 1689 |
|
|
2021
Q2 | $50K | Sell |
4,843
-36,578
| -88% | -$378K | ﹤0.01% | 1797 |
|
|
2021
Q1 | $542K | Sell |
41,421
-3,510
| -8% | -$45.9K | ﹤0.01% | 1164 |
|
|
2020
Q4 | $632K | Sell |
44,931
-62,236
| -58% | -$875K | ﹤0.01% | 1151 |
|
|
2020
Q3 | $1.27M | Sell |
107,167
-20,618
| -16% | -$245K | 0.01% | 814 |
|
|
2020
Q2 | $1.92M | Sell |
127,785
-6,777
| -5% | -$102K | 0.01% | 751 |
|
|
2020
Q1 | $970K | Buy |
134,562
+69,117
| +106% | +$498K | 0.01% | 800 |
|
|
2019
Q4 | $683K | Buy |
+65,445
| New | +$683K | ﹤0.01% | 991 |
|